
|Articles|April 23, 2020
COVID-19: Sun Pharmaceuticals business update
Author(s)Mark Hagler
Advertisement
Mark Hagler, senior vice president, head of Ophthalmics, Oncology and LTC, at Sun Pharmaceuticals, shares a business update on how the company has responded and continued operations during the coronavirus pandemic.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
2
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
3
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
4
Managing Unique Dry Eye Disease Subtypes in Patients
5

















































.png)


